Previous studies revealed that in colon cancer, the activation of TGF-β signaling induced ERK and P38 signaling and stimulated angiogenesis by VEGF upregulation when SMAD4 was knocked down [36]. Here, TGFB1 is linked to malignant colon neoplasm.